10.1016/j.addr.2018.04.008 96 SchillerH
*Compounded semaglutide and tirzepatide are not FDA-approved, are not generic versions of FDA-approved drugs like Ozempic, Wegovy, Mounjaro, or Zepbound, and are not reviewed by FDA for safety, effectiveness, or quality
Blumberg, W.I
The SUSTAIN 7 trial published in the BMJ found that participants taking 0.5 mg of semaglutide lost an average of about 10 pounds over 40 weeks
When combined, GLP-1 and TRT create a powerful synergy that aids in fat loss while helping to maintain lean muscle mass, making it particularly beneficial for those facing obesity or low testosterone levels
Retrieved from Elmaleh-Sachs, A., Schwartz, J